New Tools for Your
Fight Against COVID-19 |
| BioLegend is committed to supporting researchers in their efforts to characterize all aspects of the SARS-CoV-2 virus and COVID-19 disease, including the development of novel therapeutics, vaccines, and diagnostic tests. We’ve been working hard to expand our offerings and develop new reagents to study viral recognition, characterize inflammation, monitor cellular response, analyze anti-viral pathways, and reveal novel biomarkers. |
|
|
|
|
| Featured Products |
| ACE2 Recombinant Proteins |
SARS-CoV-2 recognizes the enzymatic domain of ACE2 on the surface of cells. BioLegend now offers bioactive human and mouse recombinant ACE2 proteins to help you investigate viral recognition.
Shop ACE2 Proteins |
|
|
|
| LEGENDplex™ Cytokine Release Syndrome Panels |
We’ve released a new multiplex assay optimized to simultaneously quantify the key biomarkers associated with cytokine release syndrome in mice, including IL-6, TNF-α, IL-10, and MIP-1α.
View Products |
|
|
|
|
|
| |
|
|
|
Login/Register 
United States ($) USD
Austria (€) EUR
Belgium (€) EUR
Finland (€) EUR
France (€) EUR
Germany (€) EUR
Ireland (€) EUR
Japan (¥) JPY
Luxembourg (€) EUR
Netherlands (€) EUR
Switzerland (CHF) CHF
United Kingdom (£) GBP
Follow Us